Login|Register|Forget password|Dashboard Back to Home|Contact|Shopcart
Unverified1st Year

Getein Biotech, Inc.  

POCT, IVD, analyzer, test kits

Search
新闻中心
  • 暂无新闻
产品分类
  • 暂无分类
联系方式
  • 联系人:Getein Biotech, Inc.
  • 电话:00000000
站内搜索
 
荣誉资质
  • 暂未上传
友情链接
  • 暂无链接
首页 > Products > Malb One Step Test Kit /Renal Marker with Ce
Malb One Step Test Kit /Renal Marker with Ce
单价 $3.40 / Piece对比
询价 暂无
浏览 270
发货 Chinajiangsunanjing
过期 长期有效
更新 2020-05-17 03:34
 
详细信息
Product Name: Malb One Step Test Kit /Renal Marker with Ce Model NO.: CG1009 Group: All Men Certification: CE, MSDS, ISO13485 Type: Poct Classification: Biological Diagnostics Suitable Machine: Fia8600/Fia8000 Trademark: GP Transport Package: Carton Specification: 25 test /BOX Origin: Jiangsu HS Code: 3002190090 Product Description The One Step Test for mAlb (colloidal gold)is intended for use together with theFIA8000 Quantitative Immunoassay Analyzer (FIA8000).The product employs colloidal gold immunochromatogrphy to determine mAlb in human urine specimen. Polyclonal antibody and recombinant antigen are employed to identify mAlb specifically, resulting in a purplish red streak appears on the test line. The color intensity of the test line increases in proportion to the concentrations of mAlb.Then insert test card into the FIA8000 Quantitative Immunoassay Analyzer, the concentration of mAlb is measured quantitatively and displayed on the screen. The result can be transmitted to the lab or hospital information system.Products Code:CG1009Detection Method:colloidal gold, a quantitative test for use with theFIA8000Quantitative Immunoassay Analyzer.Detection Range:10.0-200.0 mg/LCut-off Value:20.0 mg/LSample Type:urine.Reaction Time:yields results in about 3 minutes.Storage Temperature:4-30°CStorage Life:24 months. Use the test card within 1 hour once the foil bag is opened.PackageA box package contains 25 tests:Foil bag, which contains one test card and one desiccant25Disposable pipet25Manual1SD card1ClinicalApplication1.Indicator of Diabetic nephropathy, hypertensive nephropathy and early renal damage;2.An early indicator of changes in renal and cardiovascular system;3.Detection of Pregnancy-induced renal disease;4.An important indicator in diagnosing glomerular injury.Company ProfileGetein Biotech Inc. (stock code: 603387), established in 2002, is a fully integrated in vitro diagnostic company that researches and develops, manufactures, markets and distributes a broad range of innovative diagnostic test kits in point-of-care, clinical chemistry, chemiluminescent assays, and molecular diagnostics. The company sits on a 10.5 square kilometers science park and is equipped with state-of-the-art R&D and production facilities. It also manufactures analytic medical devices and a variety of biological and non-biological raw materials for applications in diagnostics, pharmaceuticals, and academic research.